Ipsen forges $1bn alliance with Exicure on neurodegenerative diseasesIpsen’s new chief executive David Loew pledged to ramp up spending on the company’s pipeline when he took Share XIpsen forges $1bn alliance with Exicure on neurodegenerative diseaseshttps://pharmaphorum.com/news/ipsen-forges-1bn-alliance-with-exicure-on-neurodegenerative-diseases/
Healx uses AI to find drugs for Angelman SyndromeThe UK-based AI technology company Healx has begun a partnership with the Foundation for Angelman Syndrome Therapeutics (FAST), Share XHealx uses AI to find drugs for Angelman Syndromehttps://pharmaphorum.com/news/healx-uses-ai-to-find-drugs-for-angelman-syndrome/
